Jason Thomas
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Jason Thomas has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
- Ariel Cohen
Memorial Sloan Kettering Cancer Center, Department of Surgery, Gynecology Service, New York, NY, USA
1 shared publication - John David Spencer
Kidney and Urinary Tract Center, The Abigail Wexner Research Institute at Nationwide Children’s Hospital, United States
1 shared publication - Laura Schwartz
The Kidney and Urinary Tract Center Abigail Wexner Research Institute at Nationwide Children's Columbus Ohio USA
1 shared publication
Latest Publications
- Open Access
The Immunomodulatory and Antimicrobial Properties of the Vertebrate Ribonuclease A Superfamily
The Ribonuclease A Superfamily is composed of cationic peptides that are secreted by immune cells and epithelial tissues. Although their physiological roles are unclear, several members of the vertebrate Ribonuclease A Superfamily demonstrate antimicrobial and immune modulation activities. The objective of this review is to provide an overview of the published literature on the Ribonuclease A Superfamily with an emphasis on each peptide’s regulation, antimicrobial properties, and immunomodulatory functions. As additional insights emerge regarding the mechanisms in which these ribonucleases eradicate invading pathogens and modulate immune function, these ribonucleases may have the potential to be developed as a novel class of therapeutics for some human diseases.
Open AccessThe Immunomodulatory and Antimicrobial Properties of the Vertebrate Ribonuclease A Superfamily
The Ribonuclease A Superfamily is composed of cationic peptides that are secreted by immune cells and epithelial tissues. Although their physiological roles are unclear, several members of the vertebrate Ribonuclease A Superfamily demonstrate antimicrobial and immune modulation activities. The objective of this review is to provide an overview of the published literature on the Ribonuclease A Superfamily with an emphasis on each peptide’s regulation, antimicrobial properties, and immunomodulatory functions. As additional insights emerge regarding the mechanisms in which these ribonucleases eradicate invading pathogens and modulate immune function, these ribonucleases may have the potential to be developed as a novel class of therapeutics for some human diseases.